Moulds in dwellings: Health risks and involved species;Moisissures et habitat: Risques pour la santé et espèces impliquées

Revue des Maladies Respiratoires

Volumn 27, Issue 2, 2010, Pages 169-179

  Reboux, G ^a,b   Bellanger, A P ^a,b   Roussel, S ^b   Grenouillet, F ^a,b   Millon, L ^a,b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Allergies; Indoor moulds; Infections; Mycotoxins

Indexed keywords

ENDOTOXIN; FORMALDEHYDE; MYCOTOXIN;

ALLERGIC PNEUMONITIS; ASTHMA; BRONCHITIS; CONJUNCTIVITIS; DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; FUNGAL CONTAMINATION; HEALTH HAZARD; HUMAN; HUMIDITY; MOULD; MYCOSIS; NONHUMAN; PATHOGENESIS; PUBLIC HEALTH; RESPIRATORY TRACT DISEASE; REVIEW; RHINITIS; SICK BUILDING SYNDROME; SINUSITIS;

EID: 77949540996     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmr.2009.09.003     Document Type: Short Survey

References (98)

1. Gebbers J, Glück U. Sick building syndrome. Forum Med Suisse 2003;5:109-13.
2. Fisk WJ, Lei-Gomez Q, Mendell MJ. Meta-analyses of the associations of respiratory health effects with dampness and mold in homes. Indoor Air 2007;17:284-96.
3. Santucci R, Meunier O, Ott M, Herrmann F, Freyd A, de Blay F. Fungic contamination of residence: 10 years assessment of analyses. Rev Fr Allergol 2007;47:402-8.
4. Reboux G, Bellanger AP, Roussel S, Grenouillet F, Sornin S, Piarroux R, et al. Indoor moulds concentration in Eastern France. Indoor Air 2009;1-8 doi:10.1111/j.1600-0600-0668.2009.00598.x.
5. Mallea M, Renard M, Charpin J. Fungal flora in houses. Rev Fr Mal Respir 1982;10:121-30.
6. Burge HA, Rogers CA. Outdoor allergens. Environ Health Perspect 2000;108:653-9.
7. Rautiala S, Torvinen E, Torkko P, Suomalainen S, Nevalainen A, Kalliokoski P, et al. Potentially pathogenic, slow-growing mycobacteria released into workplace air during the remediation of buildings. J Occup Environ Hyg 2004;1:1-6.
8. Suarez-Martinez EB, Montealegre F, Sierra-Montes JM, Herrera RJ. Molecular identification of pathogenic house dust mites using 12S rRNA sequences. Electrophoresis 2005;26:2927-34.
9. Terr AI. Sick building syndrome: is mould the cause? Med Mycol 2009;47:217-22.
10. Plévert L. Péril en la demeure. Eurêka 2000;52:14-9.
11. Roulet CA. Santé et qualité de l'environnement intérieur dans les bâtiments. Lausanne: Presse polytechnique et universitaire Romandes; 2004 [p. 358].
12. de Ana SG, Torres-Rodriguez JM, Ramirez EA, Garcia SM, Belmonte-Soler J. Seasonal distribution of Alternaria, Aspergillus, Cladosporium and Penicillium species isolated in homes of fungal allergic patients. J Investig Allergol Clin Immunol 2006;16:357-63.
13. Stark PC, Burge HA, Ryan LM, Milton DK, Gold DR. Fungal levels in the home and lower respiratory tract illnesses in the first year of life. Am J Respir Crit Care Med 2003;168:232-7.
14. Beguin H, Nolard N. Moulds biodiversity in homes air and surface analysis of 130 dwellings. Aerobiologia 1994;10:157-66.
15. Hyvarinen A, Vahteristo M, Meklin T, Jantunen M, Nevalainen A, Moschandreas D. Temporal and spatial variation of fungal concentrations in indoor air. Aerosol Sci Technol 2001;35:688-95.
16. Ren P, Jankun TM, Belanger K, Bracken MB, Leaderer BP. The relation between fungal propagules in indoor air and home characteristics. Allergy 2001;56:419-24.
17. Jovanovic S, Felder-Kennel A, Gabrio T, Kouros B, Link B, Maisner V, et al. Indoor fungi levels in homes of children with and without allergy history. Int J Hyg Environ Health 2004;207:369-78.
18. Mahooti-Brooks N, Storey E, Yang C, Simcox NJ, Turner W, Hodgson M. Characterization of mold and moisture indicators in the home. J Occup Environ Hyg 2004;1:826-39.
19. Kleinheinz GT, Langolf BM, Englebert E. Characterization of airborne fungal levels after mold remediation. Microbiol Res 2006;161:367-76.
20. McGinnis MR. Pathogenesis of indoor fungal diseases. Med Mycol 2004;42:107-17.
21. Reboux G, Nolard N. Moulds in indoor environments: sampling and measurement techniques. Rev Mal Respir 2007;24:243-5.
22. http://www.euro.who.int/document/e92645.pdf.
23. Womble S, Burton L, Kolb L, Girman J, Hadwen G, Carpenter M, et al. Prevalence and concentrations of culturable airborne fungal spores in 86 office buildings from the building assessment survey and evaluation (BASE) study. Indoor Air 1999;1:261-6.
24. Nesa D, Lortholary J, Bouakline A, Bordes M, Chandenier J, Derouin F, et al. Comparative performance of impactor air samplers for quantification of fungal contamination. J Hosp Infect 2001;47:149-55.
25. Cooley JD, Wong WC, Jumper CA, Straus DC. Correlation between the prevalence of certain fungi and sick building syndrome. Occup Environ Med 1998;55:579-84.
26. Koch A, Heilemann KJ, Bischof W, Heinrich J, Wichmann HE. Indoor viable mold spores - a comparison between two cities Erfurt (eastern Germany) and Hamburg (western Germany). Allergy 2000;55:176-80.
27. Hyvarinen A, Husman T, Laitinen S, Meklin T, Taskinen T, Korppi M, et al. Microbial exposure and mold-specific serum IgG levels among children with respiratory symptoms in 2 school buildings. Arch Environ Health 2003;58:275-83.
28. Park JH, Cox-Ganser JM, Kreiss K, White SK, Rao CY. Hydrophilic fungi and ergosterol associated with respiratory illness in a water-damaged building. Environ Health Perspect 2008;116:45-50.
29. Bex V, Barral S, Dusséaux L, Bordenave L, Mouilleseaux A, Squinazi F. Audits environnementaux dans l'habitat : l'expérience du laboratoire d'hygiène de la ville de Paris. J Med Mycol 2006;16:197-203.
30. http://www.sante.gouv.fr/htm/dossiers/cshpf/r-mv-0906-contamfongiques. pdf.
31. Howden-Chapman P, Saville-Smith K, Crane J, Wilson N. Risk factors for mold in housing: a national survey. Indoor Air 2005;15:469-76.
32. Roussel S, Reboux G, Bellanger AP, Sornin S, Grenouillet FJCD, Piarroux R, et al. Characteristics of dwellings contaminated by moulds. J Env Monit 2008;10:724-9.
33. Verhoeff AP, van Wijnen JH, van Reenen-Hoekstra ES, Samson RA, van Strien RT, Brunekreef B. Fungal propagules in house dust II. Relation with residential characteristics and respiratory symptoms. Allergy 1994;49:540-7.
34. Jaakkola MS, Nordman H, Piipari R, Uitti J, Laitinen J, Karjalainen A, et al. Indoor dampness and molds and development of adult-onset asthma: a population-based incident case-control study. Environ Health Perspect 2002;110:543-7.
35. Li CS, Hsu CW, Tai ML. Indoor pollution and sick building syndrome symptoms among workers in day-care centers. Arch Environ Health 1997;52:200-7.
36. Zeng QY, Westermark SO, Ramuson-Lestender A, Wang X. Detection and quantification of Cladosporium in aerosols by real-time PCR. J environ Monit 2006;8:153-60.
37. Bellanger AP, Reboux G, Roussel S, Grenouillet F, Didier-Scherer E, Dalphin JC, et al. Indoor fungal contamination of moisture-damaged and allergic patient housing analysed using real-time PCR. Lett Appl Microbiol 2009;49:260-6.
38. Morrison J, Yang C, Lin K, Haughland R, Neely A, Vesper SJ. Monitoring Aspergillus species by quantitative PCR during construction of a multi-storey hospital building. J Hosp Infect 2004;57:85-7.
39. McDevitt JJ, Lees PS, Merz WG, Schwab KJ. Development of a method to detect and quantify Aspergillus fumigatus conidia by quantitative PCR for environmental air samples. Mycopathologia 2004;158:325-35.
40. Roe J, Haughland RA, Vesper SJ, Wymer LJ. Quantification of Stachybotrys chartarum conidia in indoor dust using real time, fluorescent probe-based detection of PCR products. J Exp Anal Environ Epidemiol 2001;11:12-20.
41. Millon L, Reboux G, Bellanger A, Roussel S, Sornin S, Martin C, et al. Quantification of Stachybotrys chartarum par PCR temps réel dans l'environnment domestique, hospitalier et agricole. J Med Mycol 2006;16:183-8.
42. Haugland RA, Varma M, Wymer LJ, Vesper SJ. Quantitative PCR analysis of selected Aspergillus Penicillium and Paecilomyces species. Syst Appl Microbiol 2004;27:198-210.
43. Pitkaranta M, Meklin T, Hyvarinen A, Paulin L, Auvinen P, Nevalainen A, et al. Analysis of fungal flora in indoor dust by ribosomal DNA sequence analysis, quantitative PCR, and culture. Appl Environ Microbiol 2008;74:233-44.
44. Vesper S, McKinstry C, Haugland R, Wymer L, Bradham K, Ashley P, et al. Development of an environmental relative moldiness index for US homes. J Occup Environ Med 2007;49: 829-33.
45. Vesper SJ, McKinstry C, Haugland RA, Iossifova Y, Lemasters G, Levin L, et al. Relative moldiness index as predictor of childhood respiratory illness. J Expo Sci Environ Epidemiol 2007;17:88-94.
46. Keswani J, Kashon ML, Chen BT. Evaluation of interference to conventional and real-time PCR for detection and quantification of fungi in dust. J Environ Monit 2005;7:311-8.
47. Meklin T, Haugland RA, Reponen T, Varma M, Lummus Z, Bernstein D, et al. Quantitative PCR analysis of house dust can reveal abnormal mold conditions. J Environ Monit 2004;6:615-20.
48. Vesper SJ, Varma M, Wymer LJ, Dearborn DG, Sobolewski J, Haugland RA. Quantitative polymerase chain reaction analysis of fungi in dust from homes of infants who developed idiopathic pulmonary hemorrhaging. J Occup Environ Med 2004;46:596-601.
49. Pitt JI, Basilico JC, Abarca ML, Lopez C. Mycotoxins and toxigenic fungi. Med Mycol 2000;38:41-6.
50. Miller JD, Rand TG, Jarvis BB. Stachybotrys chartarum: cause of human disease or media darling? Med Mycol 2003;41:271-91.
51. Dearborn DG, Smith PG, Dahms BB, Allan TM, Sorenson WG, Montana E, et al. Clinical profile of 30 infants with acute pulmonary hemorrhage in Cleveland. Pediatrics 2002;110:627-37.
52. http://www.cdc.gov/nceh/airpollution/mold/moldsfacts.htm.
53. Bornehag CG, Sundell J, Bonini S, Custovic A, Malmberg P, Skerfving S, et al. Dampness in buildings as a risk factor for health effects Euroexpo: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. Indoor Air 2004;14:243-57.
54. Kuhn DM, Ghannoum MA. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective. Clin Microbiol Rev 2003;16:144-72.
55. Jacob B, Ritz B, Gehring U, Koch A, Bischof W, Wichmann HE, et al. Indoor exposure to molds and allergic sensitization. Environ Health Perspect 2002;110:647-53.
56. Stark PC, Celedon JC, Chew GL, Ryan LM, Burge HA, Muilenberg ML, et al. Fungal levels in the home and allergic rhinitis by 5 years of age. Environ Health Perspect 2005;113:1405-9.
57. Nolard N, Beguin H, Chasseur C. Mold allergy: 25 years of indoor and outdoor studies in Belgium. Allerg Immunol 2001;33:101-2.
58. Furuuchi I, Baba K. Mold allergy (Alternaria). Nippon Ika Daigaku Zasshi 1986;53:108-11.
59. Barnes C, Tuck J, Simon S, Pacheco F, Hu F, Portnoy J. Allergenic materials in the house dust of allergy clinic patients. Ann Allergy Asthma Immunol 2001;86:517-23.
60. Andersson M, Downs S, Mitakakis T, Leuppi J, Marks G. Natural exposure to Alternaria spores induces allergic rhinitis symptoms in sensitized children. Pediatr Allergy Immunol 2003;14:100-5.
61. Hasnain SM, Al-Frayh AS, Al-Suwaine A, Gad-El-Rab MO, Fatima K, Al-Sedairy S. Cladosporium and respiratory allergy: diagnostic implications in Saudi Arabia. Mycopathologia 2004;157:171-9.
62. Wan GH, Li CS. Indoor endotoxin and glucan in association with airway inflammation and systemic symptoms. Arch Environ Health 1999;54:172-9.
63. Reboux G. Mycotoxins: health effects and relationship to other organic compounds. Revue française d'allergologie et d'immunologie clinique 2006;46:208-12.
64. Mahmoudi M, Gershwin ME. Sick building syndrome III. Stachybotrys chartarum. J Asthma 2000;37:191-8.
65. Hossain MA, Ahmed MS, Ghannoum MA. Attributes of Stachybotrys chartarum and its association with human disease. J Allergy Clin Immunol 2004;113:200-8.
66. Ortiz C, Hodgson M, McNally D. Sarcoidosis and exposure to occupational and environmental agents. In: Bioaerosols, fungi and mycotoxins. E Johanning, Albany, 2001: 476-81.
67. Brakhage AA, Langfelder K. Menacing mold: the molecular biology of Aspergillus fumigatus. Annu Rev Microbiol 2002;56:433-55.
68. Kennedy SM, Shankland GS, Lee WR, Sekundo W. Keratitis due to the fungus Acremonium (Cephalosporium). Eye 1994;8:692-4.
69. Morrison VA, Haake RJ, Weisdorf DJ. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore) 1993;72:78-89.
70. Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004;113:227-34.
71. O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359-63.
72. d'Halewyn MA, Leclerc JM, King N, Bélanger M, Legris M, Frenette Y. Les risques à la santé associés à la présence de moisissure en milieu intérieur. In: Poulin M (Ed.), Institut National de la Santé Publique du Québec. INSPQ, Québec 2002:1-16.
73. Nolard N, Beguin H. Moisissures. In: Vervloet D, Magnan A, editors. Traité d'allergologie. Paris: Flammarion; 2004. p. 357-60.
74. Agarwal MK, Jones RT, Yunginger JW. Shared allergenic and antigenic determinants in Alternaria and Stemphylium extracts. J Allergy Clin Immunol 1982;70:437-44.
75. Fryen A, Mayser P, Glanz H, Fussle R, Breithaupt H, de Hoog GS. Allergic fungal sinusitis caused by Bipolaris (Drechslera) hawaiiensis. Eur Arch Otorhinolaryngol 1999;256:330-4.
76. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-50.
77. Rementeria A, Lopez-Molina N, Ludwig A, Vivanco AB, Bikandi J, Ponton J, et al. Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 2005;22:1-23.
78. Gautam P, Sundaram CS, Madan T, Gade WN, Shah A, Sirdeshmukh R, et al. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin Exp Allergy 2007;37:1239-49.
79. Singh A, Prakash D, Singh AB. Sensitization to different species of Aspergillus in bakery workers and general atopic population. Asian Pac J Allergy Immunol 1998;16:5-15.
80. Quirce S, Fernandez-Nieto M, Bartolome B, Bombin C, Cuevas M, Sastre J. Glucoamylase: another fungal enzyme associated with baker's asthma. Ann Allergy Asthma Immunol 2002;89:197-202.
81. Haverinen U, Husman T, Toivola M, Suonketo J, Pentti M, Lindberg R, et al. An approach to management of critical indoor air problems in school buildings. Environ Health Perspect 1999;107:509-14.
82. Benndorf D, Muller A, Bock K, Manuwald O, Herbarth O, von Bergen M. Identification of spore allergens from the indoor mould Aspergillus versicolor. Allergy 2008;63:454-60.
83. Dalphin J, Roussel S, Reboux G, Piarroux R. Les actualités sur les pneumopathies d'hypersensibilité en milieu rural. Rev Fr Allergol 2005;45:183-8.
84. Niedoszytko M, Chelminska M, Jassem E, Czestochowska E. Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma. Ann Allergy Asthma Immunol 2007;98:153-6.
85. Baur X, Richter G, Pethran A, Czuppon AB, Schwaiblmair M. Increased prevalence of IgG-induced sensitization and hypersensitivity pneumonitis (humidifier lung) in nonsmokers exposed to aerosols of a contaminated air conditioner. Respiration 1992;59:211-4.
86. Bessot J, Stenger R, Pauli G. Allergies respiratoires chez les vignerons. Rev Fr Allergol 1997;37:732-40.
87. Fogle MR, Douglas DR, Jumper CA, Straus DC. Growth and mycotoxin production by Chaetomium globosum. Mycopathologia 2007;164:49-56.
88. Barale T, Fumey MH, Reboux G, Malléa M, Septicémie. À Chaetomium sp. lors d'une autogreffe de moelle pour leucose aiguë lymphoblastique. Bull Soc Fr Mycol Med 1990;19:43-6.
89. Guppy KH, Thomas C, Thomas K, Anderson D. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen - Chaetomium atrobrunneum: case report. Neurosurgery 1998;43:1463-9.
90. Peternel R, Culig J, Hrga I. Atmospheric concentrations of Cladosporium spp. and Alternaria spp. spores in Zagreb (Croatia) and effects of some meteorological factors. Ann Agric Environ Med 2004;11:303-7.
91. Hogan MB, Patterson R, Pore RS, Corder WT, Wilson NW. Basement shower hypersensitivity pneumonitis secondary to Epicoccum nigrum. Chest 1996;110:854-6.
92. Edmondson DA, Nordness ME, Zacharisen MC, Kurup VP, Fink JN. Allergy and "toxic mold syndrome". Ann Allergy Asthma Immunol 2005;94:234-9.
93. Fang Z, Ouyang Z, Hu L, Wang X, Zheng H, Lin X. Culturable airborne fungi in outdoor environments in Beijing China. Sci Total Environ 2005;350:47-58.
94. Ng AS, Lau WW, Yu DK, Wong CC, Chan CW. Clinical features and outcomes of fusarium keratitis associated with contact lens wear. Eye Contact Lens 2008;34: 113-6.
95. Park HS, Jung KS, Kim SO, Kim SJ. Hypersensitivity pneumonitis induced by Penicillium expansum in a home environment. Clin Exp Allergy 1994;24:383-5.
96. Taskinen T, Meklin T, Nousiainen M, Husman T, Nevalainen A, Korppi M. Moisture and mould problems in schools and respiratory manifestations in school children: clinical and skin test findings. Acta Paediatr 1997;86:1181-7.
97. Vesper SJ, Vesper MJ. Stachylysin may be a cause of hemorrhaging in humans exposed to Stachybotrys chartarum. Infect Immun 2002;70:2065-9.
98. Adessi B, Oudet C, Chaumont J, Simeray J, Leger D. Mise en évidence d'une allergie à T. Roseum. J Med Mycol 1992;2:226-8.